YOLFTbeta
Spectral Med Inc

Spectral Med Inc

EDT · TO · Healthcare / Diagnostics & Research

1.00CAD-0.03 (-2.91%)

Price History

Full chart

Market Stats

Previous Close1.03
Open1.04
Day Range0.98 – 1.04
52-Week Range1.03 – 1.65
Volume56.09K
Market Cap344.93M
P/E (TTM)0.00
Forward P/E99.01
EPS-0.12
Dividend Yield0.00%
Beta0.18
50-Day Avg1.30
200-Day Avg1.34

About

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Christopher Seto
  • Employees29
  • Headquarters135 The West Mall, Toronto, ON, Canada, M9C 1C2, Canada
  • Websitehttps://spectraldx.com

Leadership

  • Mr. Christopher SetoCEO, Interim CFO & Director
  • Prof. John A. Kellum M.D.Chief Medical Officer

Financials

Income Statement

Currency: CAD1992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue100.00K200.00K500.00K600.00K1.50M5.40M10.50M9.80M10.97M13.24M14.49M11.75M10.00M7.27M2.17M2.99M3.01M3.28M3.04M2.43M2.59M2.67M2.96M3.09M3.54M3.67M3.84M2.87M2.10M2.00M1.67M1.60M2.29M2.44M
Growth (%)-+100.00%+150.00%+20.00%+150.00%+260.00%+94.44%-6.67%+11.96%+20.66%+9.43%-18.89%-14.89%-27.29%-70.17%+37.99%+0.60%+9.03%-7.52%-19.96%+6.54%+3.21%+10.93%+4.22%+14.76%+3.50%+4.66%-25.31%-26.74%-5.00%-16.48%-4.14%+43.05%+6.82%
Cost of Revenue-----1.20M2.00M2.00M2.70M2.82M5.44M4.89M4.45M3.45M570.00K855.00K796.00K836.00K652.00K552.00K748.00K867.00K754.00K668.00K841.00K502.00K368.00K650.00K628.00K832.00K684.00K936.00K1.27M7.60M
Gross Profit100.00K200.00K500.00K600.00K1.50M4.20M8.50M7.80M8.27M10.42M9.05M6.86M5.55M3.83M1.60M2.14M2.21M2.45M2.38M1.88M1.84M1.80M2.21M2.42M2.70M3.17M3.47M2.22M1.47M1.16M983.00K662.00K1.02M-5.16M
Gross Margin100.00%100.00%100.00%100.00%100.00%77.78%80.95%79.59%75.41%78.70%62.45%58.40%55.46%52.61%73.72%71.43%73.56%74.54%78.52%77.28%71.11%67.55%74.56%78.37%76.28%86.32%90.42%77.34%70.11%58.32%58.97%41.43%44.53%-211.14%
Operating Expense3.10M5.30M12.00M15.80M15.30M18.20M20.80M15.30M13.78M13.74M13.64M12.35M11.24M8.73M3.14M3.86M3.88M5.02M8.75M8.66M10.46M13.20M12.37M12.03M12.92M7.11M5.80M6.98M10.41M7.82M9.43M12.08M13.02M6.53M
Operating Income-3.00M-5.10M-11.50M-15.20M-13.80M-14.00M-12.30M-7.50M-5.50M-3.33M-4.59M-5.49M-5.69M-4.90M-1.54M-1.73M-1.67M-2.57M-6.37M-6.78M-8.61M-11.39M-10.16M-9.61M-10.22M-3.94M-2.33M-4.76M-8.94M-6.66M-8.45M-11.42M-12.00M-11.69M
Operating Margin-3000.00%-2550.00%-2300.00%-2533.33%-920.00%-259.26%-117.14%-76.53%-50.17%-25.12%-31.70%-46.69%-56.93%-67.41%-71.09%-57.63%-55.33%-78.34%-209.68%-278.93%-332.72%-426.27%-342.81%-311.01%-288.21%-107.36%-60.60%-166.07%-425.56%-333.52%-506.72%-714.71%-524.80%-478.50%
EBITDA-2.90M-4.70M-10.50M-13.60M-11.60M-11.20M-9.40M-4.90M-3.94M-1.84M-3.01M-3.95M-4.32M-3.58M-948.00K-1.19M-1.07M-1.94M-5.72M-6.40M-7.98M-10.64M-9.40M-8.91M-9.23M-3.17M-2.26M-4.55M-8.76M-6.38M-7.18M-13.96M-11.97M-42.27M
EBITDA Margin-2900.00%-2350.00%-2100.00%-2266.67%-773.33%-207.41%-89.52%-50.00%-35.91%-13.89%-20.79%-33.61%-43.23%-49.22%-43.71%-39.73%-35.67%-59.00%-188.47%-263.25%-308.23%-398.28%-317.00%-288.35%-260.42%-86.35%-58.83%-158.51%-417.04%-319.39%-430.71%-873.28%-523.49%-1731.16%
Net Income-3.20M-3.40M-9.00M-14.00M-13.60M-12.90M-10.30M-7.60M-5.37M-5.37M-4.43M-2.16M-7.36M-4.66M3.73M-1.67M-1.50M-2.76M-6.50M-6.71M-8.54M-11.31M-9.49M-9.52M-10.15M-4.08M-2.49M-4.86M-9.10M-8.79M-11.28M-15.66M-15.40M-47.69M
Net Income Margin-3200.00%-1700.00%-1800.00%-2333.33%-906.67%-238.89%-98.10%-77.55%-48.92%-40.55%-30.60%-18.35%-73.57%-64.01%171.97%-55.66%-49.88%-84.19%-214.03%-276.26%-329.97%-423.17%-320.24%-308.32%-286.29%-111.09%-64.82%-169.46%-433.03%-440.13%-676.72%-980.10%-673.75%-1952.99%
R&D2.00M3.10M7.70M10.20M7.70M7.10M5.70M4.60M4.26M4.09M2.27M1.66M1.82M183.00K-59.00K32.00K68.00K24.00K--236.00K273.00K16.00K67.00K238.00K110.00K---3.10M4.68M3.97M4.33M
R&D as % of Total Revenue2000.00%1550.00%1540.00%1700.00%513.33%131.48%54.29%46.94%38.82%30.86%15.65%14.15%18.24%2.52%-1.97%1.06%2.07%0.79%--8.83%9.21%0.52%1.89%6.49%2.86%---185.96%292.62%173.80%177.48%
Interest Expense01.70M2.50M1.20M300.00K1.10M2.00M300.00K58.00K163.00K3.34M564.00K1.44M1.89M288.00K165.00K164.00K164.00K164.00K0318.00K427.00K554.00K445.00K693.00K686.00K893.00K36.00K32.00K28.00K176.00K1.33M3.18M5.16M
Interest Expense % of Total Revenue0.00%850.00%500.00%200.00%20.00%20.37%19.05%3.06%0.53%1.23%23.05%4.80%14.40%26.00%13.28%5.51%5.45%5.00%5.40%0.00%12.28%15.98%18.69%14.41%19.55%18.70%23.26%1.26%1.52%1.40%10.56%83.48%138.98%211.47%

Balance Sheet

Currency: CAD1992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets4.50M16.80M40.90M30.60M42.50M30.30M22.30M16.20M13.45M18.07M14.04M19.71M15.58M11.56M9.34M7.98M7.08M5.03M17.30M20.65M12.59M9.44M11.86M8.46M7.10M3.47M6.98M4.01M8.16M11.55M12.00M5.21M5.32M6.10M
Total Liabilities700.00K900.00K1.60M2.20M3.40M4.00M6.30M6.90M7.64M9.89M10.20M10.68M10.25M10.82M2.35M2.54M3.03M3.67M1.55M1.71M2.01M3.74M3.04M3.03M1.28M615.00K607.00K1.75M8.83M7.47M14.55M21.76M32.87M75.82M
Total Equity3.80M15.90M39.30M28.40M39.10M26.30M16.00M9.30M5.81M8.19M3.84M9.03M5.33M738.00K6.99M5.44M4.05M1.36M15.87M18.94M10.57M5.70M8.82M5.43M5.82M2.86M6.37M2.26M-669.00K4.08M-2.55M-16.55M-27.55M-69.72M
Cash2.90M9.90M32.20M18.40M29.10M14.50M6.70M5.10M3.32M6.39M1.01M2.07M1.69M4.00M945.00K638.00K297.00K2.94M10.31M13.47M5.42M7.23M10.05M6.37M5.08M1.45M4.37M1.44M5.81M8.89M8.41M2.95M2.99M4.07M
Total Debt200.00K200.00K200.00K800.00K800.00K400.00K2.20M4.00M4.39M5.80M7.76M8.42M8.67M9.60M1.84M2.01M2.17M2.34M---------744.00K667.00K582.00K7.57M8.56M14.93M21.09M
Net Debt-2.70M-9.70M-32.00M-17.60M-28.30M-14.10M-4.50M-1.10M1.07M-583.00K6.75M6.35M6.98M5.59M898.00K1.37M1.88M-608.00K-10.31M-13.47M-5.42M-7.23M-10.05M-6.37M-5.08M-1.45M-4.37M-691.00K-5.14M-8.31M-1.77M5.61M11.94M17.02M

Cash Flow

Currency: CAD1992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-2.30M-3.20M-7.50M-12.40M-10.90M-10.00M-9.00M-4.50M-3.80M615.00K-4.18M-5.01M-5.06M-4.21M-1.27M-732.00K-523.00K-1.11M-4.48M-6.27M-7.72M-9.19M-10.01M-9.14M-11.13M-3.60M-2.38M-2.74M-324.00K-8.70M-9.90M-10.72M-8.82M-11.63M
Investing Cash Flow-500.00K-5.40M-2.60M-4.90M-2.80M-4.20M-200.00K1.00M120.00K-586.00K-516.00K-273.00K-411.00K5.43M-1.79M421.00K182.00K3.75M-5.81M-131.00K-320.00K4.79M-44.00K-381.00K-122.00K-120.00K-47.00K-161.00K-297.00K-325.00K-33.00K-185.00K-27.00K-195.00K
Financing Cash Flow5.20M15.60M32.40M3.60M24.30M-300.00K1.50M1.90M1.90M3.04M-684.00K6.35M5.09M1.08M-4.00K--17.66M9.56M-6.20M12.88M5.83M9.96M84.00K5.29M23.00K5.18M12.16M9.46M5.44M8.88M12.91M
Capital Expenditure500.00K5.40M2.20M4.20M1.20M900.00K700.00K300.00K263.00K344.00K141.00K262.00K411.00K216.00K81.00K324.00K235.00K129.00K727.00K66.00K269.00K343.00K60.00K403.00K122.00K135.00K47.00K161.00K315.00K483.00K33.00K185.00K27.00K195.00K
Free Cash Flow-2.80M-8.60M-9.70M-16.60M-12.10M-10.90M-9.70M-4.80M-4.07M271.00K-4.32M-5.27M-5.47M-4.42M-1.35M-1.06M-758.00K-1.24M-5.20M-6.34M-7.99M-9.53M-10.07M-9.54M-11.25M-3.73M-2.37M-2.90M-639.00K-9.18M-9.93M-10.91M-8.85M-9.72M
Dividends Paid-------------------------------000
FCF to OCF121.74%268.75%129.33%133.87%111.01%109.00%107.78%106.67%106.91%44.07%103.37%105.23%108.12%105.13%106.38%144.26%144.93%111.64%116.24%101.05%103.48%103.73%100.60%104.41%101.10%103.76%99.50%105.88%197.22%105.55%100.33%101.73%100.31%83.55%
Dividend Paid to FCF-------------------------------0.00%0.00%0.00%

Earnings

Report DateAug 29, 1995Nov 29, 1995Feb 29, 1996Jun 30, 2001Sep 30, 2001Dec 31, 2001Mar 31, 2002Jun 30, 2002Sep 30, 2002Dec 31, 2002Aug 13, 2003Nov 12, 2003Feb 25, 2004Jun 9, 2004Aug 13, 2004Nov 12, 2004Feb 14, 2005Jun 9, 2005Mar 7, 2008May 14, 2008Aug 13, 2008Nov 12, 2008Mar 12, 2009May 15, 2009Aug 13, 2009Nov 12, 2009May 14, 2010Aug 12, 2010Nov 15, 2010Mar 11, 2011May 13, 2011Aug 12, 2011Nov 11, 2011Mar 9, 2012May 11, 2012Aug 10, 2012Nov 9, 2012Mar 27, 2013May 15, 2013Aug 13, 2013Nov 13, 2013Mar 27, 2014May 15, 2014Aug 13, 2014Nov 13, 2014Mar 25, 2015May 13, 2015Aug 14, 2015Nov 13, 2015Mar 30, 2016May 12, 2016Aug 12, 2016Nov 11, 2016Mar 30, 2017May 12, 2017Aug 11, 2017Nov 14, 2017Mar 29, 2018May 11, 2018Aug 14, 2018Nov 14, 2018Mar 28, 2019May 9, 2019Aug 15, 2019Nov 14, 2019Mar 27, 2020May 15, 2020Aug 14, 2020Nov 11, 2020Mar 26, 2021May 14, 2021Aug 13, 2021Nov 12, 2021Mar 24, 2022May 13, 2022Aug 12, 2022Nov 10, 2022Mar 24, 2023May 12, 2023Aug 10, 2023Nov 9, 2023Mar 27, 2024May 13, 2024Aug 9, 2024Nov 8, 2024Mar 26, 2025May 9, 2025Aug 8, 2025Nov 7, 2025Mar 26, 2026May 8, 2026Aug 7, 2026Nov 6, 2026
EPS Estimate-0.32-0.22-0.11----------0.01--0.05-0.08-0.04------------------------0.02-0.02-0.01-0.01-0.02-0.02-0.02-0.01-0.01--0.02-0.01-0.01-0.01-0.01-0.01-0.01-0.01--0.01-0.01-0.01---0.01-0.010.010.00-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-------0.01-0.02-0.01-0.01-0.01
EPS Actual-0.46-0.58-0.510.11-0.12-0.13-0.23-0.10-0.06-0.03-0.060.13-0.07-0.12-0.08-0.11-0.12-0.09-0.03-0.02-0.02-0.01-0.01-0.02-0.03-0.02-0.05-0.02-0.02-0.03-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.03-0.02-0.02-0.01-0.01-0.01-0.01-0.01-0.01-0.02-0.02-0.01-0.00-0.00-0.01-0.00-0.01-0.00-0.01-0.000.00-0.00-0.00-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.02-0.01-0.02-0.040.01-0.04-0.01-0.11-0.01-0.010.00-
Surprise-43.75%-163.64%-363.64%----------600.00%--60.00%-37.50%-200.00%-----------------------0.00%-50.00%-100.00%-100.00%50.00%50.00%50.00%0.00%0.00%-0.00%-100.00%0.00%51.00%54.00%46.00%60.00%0.00%-32.00%69.00%120.00%--0.00%0.00%-200.00%-0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-100.00%-------1000.00%50.00%0.00%111.00%-
Timing----------------------------------------Pre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap344.93M
Enterprise Value350.72M
Trailing P/E0.00
Forward P/E99.01
Price / Sales134.26
Price / Book52.98
EPS-0.12
Book Value-0.239
Revenue (TTM)2.57M
Gross Profit (TTM)1.36M
EBITDA-10.34M
Profit Margin0.00%
Operating Margin-338.65%
Return on Equity-973.97%
Return on Assets-150.77%
Shares Outstanding293.55M
Shares Float288.11M
Beta0.18
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20111×
0.12Dec 19, 2011